Previous Chapter: 3 CONCLUSIONS AND FUTURE RESEARCH DIRECTIONS
Suggested Citation: "APPENDIX: WORKSHOP AGENDA, SPEAKERS, AND PARTICIPANTS." Institute of Medicine. 1997. Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/5854.

Appendix

Workshop Agenda, Speakers, and Participants

Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations

Institute of Medicine

National Academy of Sciences

Committee on Pharmacokinetics and Drug Interactions in the Elderly

April 9, 1997

Xavier University of Louisiana

College of Pharmacy

New Orleans, LA

AGENDA

8:30–9:15 a.m.

Welcome

 

Marcellus Grace

Dean

College of Pharmacy

Xavier University of Louisiana

 

John Ruffin

Director

NIH Office of Research on Minority Health

 

J. Taylor Harden

Assistant to the Director for Special Populations

National Institute on Aging

 

Leslie Z. Benet, Committee Chair

University of California, San Francisco

Suggested Citation: "APPENDIX: WORKSHOP AGENDA, SPEAKERS, AND PARTICIPANTS." Institute of Medicine. 1997. Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/5854.
 

Definition of the Elderly Population

 

Janice Schwartz

Northwestern University Medical School

MORNING SESSION

State of the Science and Future Opportunities

9:15–10:00 a.m.

Physiology of Aging

 

What are the age, gender, race, disease, and environment related factors influencing physiology as they impact pharmacotherapy?

 

Overview

 

Fran E. Kaiser

St. Louis University

 

Hypertension in Elderly African Americans

 

Keith Ferdinand

Xavier University of Louisiana

10:00–11:00 a.m.

Intracellular Function

 

What are the age, gender, race, disease, and environment related factors influencing intracellular function as they impact pharmacotherapy?

 

Kinetics—Enzymes and Transport Proteins

 

Grant Wilkinson

Vanderbilt University

 

Receptors

 

Physiologic

 

Darrell R. Abernethy

Georgetown University Medical Center

 

Neurologic

 

Kurt Rasmussen

Eli Lilly and Company, Inc.

11:00–11:30 a.m.

DISCUSSION

Suggested Citation: "APPENDIX: WORKSHOP AGENDA, SPEAKERS, AND PARTICIPANTS." Institute of Medicine. 1997. Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/5854.
 

11:30 a.m.–12:15 p.m.

Response and Outcomes

 

What are the age, gender, race, disease, and environment related factors influencing response and outcomes?

 

Response

 

Jeffrey Halter

University of Michigan

 

Outcomes—Pharmacoepidemiology

 

Jane Cauley

University of Pittsburgh

 

Economics of Pharmacotherapy

 

Andy Stergachis

University of Washington

12:15–12:45 p.m.

DISCUSSION

12:45–1:30 p.m.

LUNCH

AFTERNOON SESSION

Resources and Opportunities

What are the barriers and opportunities related to age, gender, race, disease, and the environment in pharmacotherapy research?

1:30–2:30 p.m.

Recruitment of Study Participants

 

Defining the Study Population

 

Nanette Wenger

Emory University

 

Greg Sachs

University of Chicago

 

Issues in Recruiting and Retaining African

 

Americans in Clinical Trials

 

Techniques in Recruitment

 

Jackson Wright

Case Western University

 

Compliance and Other Issues

 

Richard Corriveau

Xavier University of Louisiana

Suggested Citation: "APPENDIX: WORKSHOP AGENDA, SPEAKERS, AND PARTICIPANTS." Institute of Medicine. 1997. Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/5854.

2:30–3:30 p.m.

Chronic Medication Use

 

Pharmaceuticals

 

Bruce Pollock

University of Pittsburgh

 

Nutraceuticals

 

Louis Lasagna

Tufts University

 

Methodology

 

Wayne Ray

Vanderbilt University

3:30–3:45 p.m.

BREAK

3:45–4:00 p.m.

Dissemination of Information to Prescribers, Pharmacists, Patients

 

Stephen Pauker

New England Medical Center

4:00–4:20 p.m.

Investigators/Funding

 

Jesse Roth

Johns Hopkins University School of Medicine

4:20–5:10 p.m.

DISCUSSION

5:10–5:30 p.m.

Summary

 

Marcus Reidenberg

Cornell University Medical Center

5:30 p.m.

Adjourn

Suggested Citation: "APPENDIX: WORKSHOP AGENDA, SPEAKERS, AND PARTICIPANTS." Institute of Medicine. 1997. Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/5854.

SPEAKERS

Darrell R. Abernethy

Francis Cabell Brown Professor of Medicine and Pharmacology

Director

Division of Clinical Pharmacology

Georgetown University Medical Center

Washington, DC

Leslie Z. Benet

Professor and Chairman

Department of Biopharmaceutical Sciences

University of California, San Francisco

San Francisco, CA

Jane Cauley

Associate Professor

Graduate School of Public Health

University of Pittsburgh

Pittsburgh, PA

Richard Corriveau

Director, Clinical Trials Unit

College of Pharmacy

Xavier University of Louisiana

New Orleans, LA

Keith Ferdinand

Associate Professor, Clinical Pharmacology

Medical Director, Heartbeats Life Center

College of Pharmacy

Xavier University of Louisiana

New Orleans, LA

Marcellus Grace

Dean

College of Pharmacy

Xavier University of Louisiana

New Orleans, LA

Jeffrey Halter

Director

University of Michigan Geriatrics Center

Ann Arbor, MI

J. Taylor Harden

Assistant Director for Special Populations

National Institute on Aging

Bethesda, MD

Fran E. Kaiser

Professor of Medicine

Division of Geriatric Medicine

St. Louis University Medical Center

St. Louis, MO

Louis Lasagna

Dean for Scientific Affairs

Tufts University School of Medicine

Boston, MA

Stephen G. Pauker

Vice-Chairman for Clinical Affairs

Department of Medicine

New England Medical Center

Boston, MA

Suggested Citation: "APPENDIX: WORKSHOP AGENDA, SPEAKERS, AND PARTICIPANTS." Institute of Medicine. 1997. Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/5854.

Bruce Pollock

Professor of Psychiatry and Pharmacology

University of Pittsburgh School of Medicine

Pittsburgh, PA

Kurt Rasmussen

Neuroscience Research

Therapeutic Area Discovery Research and Clinical Investigation

Eli Lilly & Company, Inc.

Indianapolis, IN

Wayne Ray

Professor

Department of Preventive Medicine and Public Health

Vanderbilt University School of Medicine

Nashville, TN

Marcus M. Reidenberg

Clinical Pharmacology and Therapeutics

Cornell University Medical Center

New York, NY

Jesse Roth

Raymond and Anna Lublin Professor of Medicine

Director, Division of Geriatric Medicine

Johns Hopkins University School of Medicine

Baltimore, MD

John Ruffin

Director

Office of Research on Minority Health

National Institutes of Health

Bethesda, MD

Greg A. Sachs

Assistant Professor of Medicine

University of Chicago Medical Center

Chicago, IL

Janice B. Schwartz

Professor of Medicine

Chief of Clinical Pharmacology and Geriatric Medicine

Northwestern University Medical School

Chicago, IL

Andy Stergachis

Professor of Pharmacy and Epidemiology

Chairman, Department of Pharmacy

University of Washington School of Pharmacy

Seattle, WA

Nanette Wenger

Professor of Medicine, Cardiology

Emory University School of Medicine

Atlanta, GA

Grant R. Wilkinson

Professor of Pharmacology

Associate Director, Division of Clinical Pharmacology

Vanderbilt University School of Medicine

Nashville, TN

Jackson T. Wright

Director, Clinical Hypertension Program

Department of Medicine

Case Western Reserve University

Cleveland, OH

Suggested Citation: "APPENDIX: WORKSHOP AGENDA, SPEAKERS, AND PARTICIPANTS." Institute of Medicine. 1997. Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/5854.

PARTICIPANTS

Edwin H. Adams

School of Pharmacy

Northeast Louisiana University

West Monroe, LA

Theodore R. Bates

Professor of Pharmaceutics

Texas Southern University

Houston, TX

Mark H. Beers

Senior Director of Geriatrics

Merck & Co., Inc.

West Point, PA

Levon Bostinian

Assistant Professor

College of Pharmacy

Xavier University of Louisiana

New Orleans, LA

D. Craig Brater

Chairman

Department of Medicine

Indiana University School of Medicine

Indianapolis, IN

Louise Cheung

Assistant Professor of Pharmaceutics

Texas Southern University

Houston, TX

Janice L. Feinberg

Director

American Society of Consultant Pharmacists (ASCP) Foundation

Alexandria, VA

David J. Greenblatt

Professor and Chairman

Department of Pharmacology and Experimental Therapeutics

Tufts University

Boston, MA

Barbara E. Hayes

College of Pharmacy and Health Sciences

Texas Southern University

Houston, TX

Burde Kamath

Associate Professor

Biopharmaceutics and Pharmacokinetics

College of Pharmacy

Xavier University of Louisiana

New Orleans, LA

Patricia D. Kroboth

Professor and Chair

Department of Pharmaceutical Sciences

University of Pittsburgh School of Pharmacy

Pittsburgh, PA

Catharyn T. Liverman

Program Officer

Institute of Medicine

Washington, D.C.

Henri R. Manasse, Jr.

Executive Vice President

American Society of Health System Pharmacists

Bethesda, MD

Suggested Citation: "APPENDIX: WORKSHOP AGENDA, SPEAKERS, AND PARTICIPANTS." Institute of Medicine. 1997. Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/5854.

C. David Matthews

Assistant Professor

Clinical Practice

Northeast Louisiana University

West Monroe, LA

Joseph M. Moerschbaecher

Professor and Head

Department of Pharmacology

Louisiana State University Medical Center

New Orleans, LA

Mark Monane

Director

Disease State Management-Geriatrics

Merck Medco Managed Care

Montvale, NJ

Constance M. Pechura

Director

Division of Neuroscience and Behavioral Health

Institute of Medicine

Washington, D.C.

Judith A. Salerno

Chief Consultant

Geriatrics and Extended Care

Department of Veterans Affairs

Washington, DC

Daniel Sarpong

ssistant Professor of Biostatistics

College of Pharmacy

Xavier University of Louisiana

New Orleans, LA

Marvin Scott

Assistant Professor, Pharmacy Practice

College of Pharmacy and Pharmaceutical Sciences

Florida A&M University

Tallahassee, FL

Stanley Slater

eputy Associate Director Geriatrics Program

National Institute on Aging

Washington, DC

Robert Taylor

Chairman

Department of Pharmacology

Howard University College of Medicine

Washington, DC

Vasant Telang

Interim Dean

College of Pharmacy

Howard University

Washington, DC

Alice E. Till

Vice President for Scientific Affairs

Generic Pharmaceutical Industry Association

Washington, DC

Suggested Citation: "APPENDIX: WORKSHOP AGENDA, SPEAKERS, AND PARTICIPANTS." Institute of Medicine. 1997. Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/5854.
Page 43
Suggested Citation: "APPENDIX: WORKSHOP AGENDA, SPEAKERS, AND PARTICIPANTS." Institute of Medicine. 1997. Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/5854.
Page 44
Suggested Citation: "APPENDIX: WORKSHOP AGENDA, SPEAKERS, AND PARTICIPANTS." Institute of Medicine. 1997. Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/5854.
Page 45
Suggested Citation: "APPENDIX: WORKSHOP AGENDA, SPEAKERS, AND PARTICIPANTS." Institute of Medicine. 1997. Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/5854.
Page 46
Suggested Citation: "APPENDIX: WORKSHOP AGENDA, SPEAKERS, AND PARTICIPANTS." Institute of Medicine. 1997. Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/5854.
Page 47
Suggested Citation: "APPENDIX: WORKSHOP AGENDA, SPEAKERS, AND PARTICIPANTS." Institute of Medicine. 1997. Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/5854.
Page 48
Suggested Citation: "APPENDIX: WORKSHOP AGENDA, SPEAKERS, AND PARTICIPANTS." Institute of Medicine. 1997. Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/5854.
Page 49
Suggested Citation: "APPENDIX: WORKSHOP AGENDA, SPEAKERS, AND PARTICIPANTS." Institute of Medicine. 1997. Pharmacokinetics and Drug Interactions in the Elderly and Special Issues in Elderly African-American Populations: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/5854.
Page 50
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.